LUMOSA THERAPEUTICS
Lumosa Therapeutics, a public traded company in Taipei Exchange (6535.TWO), is dedicated to the development of innovative new drugs for the treatment of neurological and inflammatory diseases of unmet medical needs. The company is actively engaged in scientific in-licensing and new drug development under the “reSEARCH and DEVELOPMENT” model. This model is executed by a highly capable and experienced cross-functional teams of translational research, CMC, preclinical, clinical development, project management, regulatory affairs, intellectual property and business development experts.
LUMOSA THERAPEUTICS
Industry:
Biotechnology
Founded:
2001-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.lumosa.com.tw
Total Employee:
101+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Apache
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.lumosa.com.tw Semrush global rank: 9.22 M Semrush visits lastest month: 192
- Host name: 125-227-145-14.hinet-ip.hinet.net
- IP address: 125.227.145.14
- Location: Taipei Taiwan
- Latitude: 25.0478
- Longitude: 121.5318
- Timezone: Asia/Taipei
More informations about "Lumosa Therapeutics"
Lumosa Therapeutic Organization Chart | Lumosa …
Director, Pre-clinical Development Division, Lumosa Therapeutics; Naomi Liu. Senior Director, New Drug Development Division. Expertise. Strategic planning and development of new drug; New drug evaluation and project management, …See details»
Lumosa Therapeutics - lumosa.com.tw
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to create solution for neurological and oncological diseases with urgent unmet medical needs. Lumosa. Better Therapy Brighter Outlook. About Mission and …See details»
Member Profile - TRPMA Official Website
Merger of SunTen Phytotech, Cheng Pang Biopharma, and BroadCan Company; name change to Lumosa Therapeutics Co., Ltd. (Lumosa). 2016 Lumosa Therapeutics is public traded on Taipei Exchange (code: 6535.TWO) 2017 …See details»
Lumosa Therapeutics | Lumosa Therapeutics - lumosa.com.tw
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to create solution …See details»
Lumosa Therapeutics Co., Ltd. Information - RocketReach
Lumosa Therapeutics, a public traded company in Taipei Exchange (6535.TWO), is dedicated …See details»
Center Ventures | Lumosa Therapeutics
Lumosa Therapeutics (Stock code: 6535.TW) is the "new drug development harbor in Taiwan," …See details»
Lumosa Therapeutics - Crunchbase Company Profile
Lumosa Therapeutics, a public traded company in Taipei Exchange (6535.TWO), is dedicated to the development of innovative new drugs for the treatment of neurological and inflammatory diseases of unmet medical needs. The …See details»
Lumosa Therapeutics Company Description - Stock Analysis
Lumosa Therapeutics Co., Ltd., a clinical-stage pharmaceutical company, develops therapies …See details»
Company Lumosa Therapeutics Co., Ltd. - MarketScreener.com
Jul 2, 2006 LUMOSA THERAPEUTICS CO., LTD. is a Taiwan-based company principally …See details»
Lumosa Therapeutics
Lumosa's main suppliers are domestic and foreign pharmaceutical R&D service companies …See details»
Lumosa Therapeutics Co., Ltd. (Taiwan, China) - EMIS
Jul 5, 2024 Financial values in the chart are available after Lumosa Therapeutics Co., Ltd. …See details»
Lumosa Therapeutics - Overview, News & Similar companies
Lumosa Therapeutics contact info: Phone number: +886 226557919 Website: …See details»
Lumosa Therapeutics Company - PitchBook
Mar 22, 2021 Lumosa Therapeutics Company General Information Description. Lumosa …See details»
Nextsource | Company Profile | Lumosa Therapeutics
Website: lumosa.com.tw. Phone Number: N/A. Revenue: $$$$ Company Type: For Profit. …See details»
Chief Executive Officer at Lumosa Therapeutics - ZoomInfo
Rongjin Lin contact details: Email address: r***@lumosa.com.tw Phone number: +886 * **** …See details»
Lumosa Therapeutics
Lumosa Therapeutics is a clinical-stage pharmaceutical company dedicating to develop novel …See details»
LUMOSA THERAPEUTICS 2019Q3 INVESTORS CONFERENCE - TWSE
Lumosa’swork: • Supply agreement and preparation: Lumosa to provide quotation to SVP. SVP …See details»
BIO Asia–Taiwan 2025 亞洲生技大會
Prior to Joining AnnJi in 2019, she was President and CEO of Lumosa Therapeutics since …See details»
Lumosa Therapeutics - lumosa.com.tw
Lumosa dedicated a total of 6 classes, or 12 hours, to teaching. To call for staffs' concerns in …See details»
Lumosa Therapeutics (TPEX:6535) - mops.twse.com.tw
Lumosa Therapeutics (TPEX:6535) 2024/11/29. 2 Forward-looking Statements Disclaimer ...See details»